| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 7.78e-07 | 11 | 142 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.32e-06 | 14 | 142 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.15e-06 | 37 | 142 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.15e-06 | 37 | 142 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.04e-06 | 38 | 142 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.34e-05 | 21 | 142 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.84e-05 | 46 | 142 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 5.57e-05 | 11 | 142 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | stretch-activated, monoatomic cation-selective, calcium channel activity | 1.50e-04 | 3 | 142 | 2 | GO:0015275 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.50e-04 | 38 | 142 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.50e-04 | 79 | 142 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.52e-04 | 231 | 142 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SLK SAMD8 AK9 ERVK-7 ERVK-10 BLK CCNE1 AATK PIK3C2B PIK3C3 PIK3CD ERVK-8 PRKAG1 KDR MAP3K15 PPIP5K2 ERVK-11 | 3.68e-04 | 938 | 142 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | endonuclease activity | 4.29e-04 | 136 | 142 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 8.12e-04 | 26 | 142 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | RARS1 ETF1 ERVK-7 ERVK-10 DROSHA ERVK-8 DDX60L TRMT5 ERVK-11 DDX24 | 8.14e-04 | 417 | 142 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 DOCK3 ARHGEF28 ABR DOCK11 ARHGAP10 SRGAP2 ANKRD27 SRGAP1 EIF2B3 VAV2 | 1.02e-03 | 507 | 142 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 DOCK3 ARHGEF28 ABR DOCK11 ARHGAP10 SRGAP2 ANKRD27 SRGAP1 EIF2B3 VAV2 | 1.02e-03 | 507 | 142 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.03e-03 | 7 | 142 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 1.03e-03 | 7 | 142 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.13e-03 | 321 | 142 | 8 | GO:0031267 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.77e-08 | 13 | 142 | 5 | GO:0015074 | |
| Domain | srGAP2 | 3.78e-07 | 3 | 136 | 3 | IPR030252 | |
| Domain | FCH | 1.78e-05 | 22 | 136 | 4 | PF00611 | |
| Domain | FCH | 1.78e-05 | 22 | 136 | 4 | SM00055 | |
| Domain | PI3K_C2 | 2.06e-05 | 8 | 136 | 3 | SM00142 | |
| Domain | PI3K_C2_dom | 2.06e-05 | 8 | 136 | 3 | IPR002420 | |
| Domain | PI3K_C2 | 2.06e-05 | 8 | 136 | 3 | PF00792 | |
| Domain | PI3K_C2 | 2.06e-05 | 8 | 136 | 3 | PS51547 | |
| Domain | FCH_dom | 2.14e-05 | 23 | 136 | 4 | IPR001060 | |
| Domain | F_BAR | 3.02e-05 | 25 | 136 | 4 | IPR031160 | |
| Domain | F_BAR | 3.02e-05 | 25 | 136 | 4 | PS51741 | |
| Domain | PI3Ka | 3.07e-05 | 9 | 136 | 3 | PF00613 | |
| Domain | PI3Ka | 3.07e-05 | 9 | 136 | 3 | SM00145 | |
| Domain | - | 3.07e-05 | 9 | 136 | 3 | 1.25.40.70 | |
| Domain | PI_Kinase | 4.37e-05 | 10 | 136 | 3 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 4.37e-05 | 10 | 136 | 3 | IPR001263 | |
| Domain | PIK_HELICAL | 4.37e-05 | 10 | 136 | 3 | PS51545 | |
| Domain | FAM155 | 5.26e-05 | 2 | 136 | 2 | IPR029604 | |
| Domain | DHR-1_domain | 5.97e-05 | 11 | 136 | 3 | IPR027007 | |
| Domain | DHR_2 | 5.97e-05 | 11 | 136 | 3 | PS51651 | |
| Domain | DHR_1 | 5.97e-05 | 11 | 136 | 3 | PS51650 | |
| Domain | DHR-2 | 5.97e-05 | 11 | 136 | 3 | PF06920 | |
| Domain | DOCK | 5.97e-05 | 11 | 136 | 3 | IPR026791 | |
| Domain | DOCK_C | 5.97e-05 | 11 | 136 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 5.97e-05 | 11 | 136 | 3 | PF14429 | |
| Domain | DHR-2 | 5.97e-05 | 11 | 136 | 3 | IPR027357 | |
| Domain | Vps26-related | 1.57e-04 | 3 | 136 | 2 | IPR028934 | |
| Domain | Vps26 | 1.57e-04 | 3 | 136 | 2 | PF03643 | |
| Domain | PI3/4_kinase_CS | 1.61e-04 | 15 | 136 | 3 | IPR018936 | |
| Domain | SH3 | 1.86e-04 | 216 | 136 | 8 | SM00326 | |
| Domain | SH3 | 1.86e-04 | 216 | 136 | 8 | PS50002 | |
| Domain | - | 1.97e-04 | 16 | 136 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.97e-04 | 16 | 136 | 3 | SM00146 | |
| Domain | SH3_1 | 2.00e-04 | 164 | 136 | 7 | PF00018 | |
| Domain | SH3_domain | 2.11e-04 | 220 | 136 | 8 | IPR001452 | |
| Domain | PI3_PI4_kinase | 2.84e-04 | 18 | 136 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.84e-04 | 18 | 136 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.84e-04 | 18 | 136 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 2.84e-04 | 18 | 136 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 2.84e-04 | 18 | 136 | 3 | PS50290 | |
| Domain | PBC | 3.13e-04 | 4 | 136 | 2 | PF03792 | |
| Domain | PBX | 3.13e-04 | 4 | 136 | 2 | IPR005542 | |
| Domain | DOCK_N | 5.19e-04 | 5 | 136 | 2 | PF16172 | |
| Domain | DOCK_N | 5.19e-04 | 5 | 136 | 2 | IPR032376 | |
| Domain | NACHT | 6.01e-04 | 23 | 136 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 6.01e-04 | 23 | 136 | 3 | IPR007111 | |
| Domain | - | 7.55e-04 | 148 | 136 | 6 | 2.60.40.150 | |
| Domain | Acid_Pase_AS | 7.75e-04 | 6 | 136 | 2 | IPR033379 | |
| Domain | C1_1 | 7.88e-04 | 57 | 136 | 4 | PF00130 | |
| Domain | TPR-contain_dom | 8.10e-04 | 150 | 136 | 6 | IPR013026 | |
| Domain | ARM-type_fold | 8.55e-04 | 339 | 136 | 9 | IPR016024 | |
| Domain | PI3K_Ras-bd_dom | 1.08e-03 | 7 | 136 | 2 | IPR000341 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 1.08e-03 | 7 | 136 | 2 | PS00778 | |
| Domain | PI3K_rbd | 1.08e-03 | 7 | 136 | 2 | SM00144 | |
| Domain | PI3K_rbd | 1.08e-03 | 7 | 136 | 2 | PF00794 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 1.08e-03 | 7 | 136 | 2 | PS00616 | |
| Domain | PI3K_RBD | 1.08e-03 | 7 | 136 | 2 | PS51546 | |
| Domain | RhoGAP | 1.08e-03 | 62 | 136 | 4 | SM00324 | |
| Domain | RhoGAP | 1.15e-03 | 63 | 136 | 4 | PF00620 | |
| Domain | RhoGAP_dom | 1.22e-03 | 64 | 136 | 4 | IPR000198 | |
| Domain | ZF_DAG_PE_1 | 1.22e-03 | 64 | 136 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.22e-03 | 64 | 136 | 4 | PS50081 | |
| Domain | RHOGAP | 1.22e-03 | 64 | 136 | 4 | PS50238 | |
| Domain | - | 1.22e-03 | 64 | 136 | 4 | 1.10.555.10 | |
| Domain | C2_dom | 1.28e-03 | 164 | 136 | 6 | IPR000008 | |
| Domain | C1 | 1.29e-03 | 65 | 136 | 4 | SM00109 | |
| Domain | TPR_REGION | 1.33e-03 | 165 | 136 | 6 | PS50293 | |
| Domain | TPR | 1.33e-03 | 165 | 136 | 6 | PS50005 | |
| Domain | PE/DAG-bd | 1.37e-03 | 66 | 136 | 4 | IPR002219 | |
| Domain | His_Pase_clade-2 | 1.43e-03 | 8 | 136 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 1.43e-03 | 8 | 136 | 2 | PF00328 | |
| Domain | NPY_rcpt | 1.83e-03 | 9 | 136 | 2 | IPR000611 | |
| Domain | TPR_repeat | 2.90e-03 | 133 | 136 | 5 | IPR019734 | |
| Domain | C2 | 3.30e-03 | 137 | 136 | 5 | SM00239 | |
| Domain | Rho_GTPase_activation_prot | 3.91e-03 | 88 | 136 | 4 | IPR008936 | |
| Domain | - | 4.11e-03 | 207 | 136 | 6 | 1.25.40.10 | |
| Domain | A/G_cyclase_CS | 6.66e-03 | 17 | 136 | 2 | IPR018297 | |
| Domain | Cyclin_C-dom | 6.66e-03 | 17 | 136 | 2 | IPR004367 | |
| Domain | Cyclin_C | 6.66e-03 | 17 | 136 | 2 | PF02984 | |
| Domain | Cyclin_C | 6.66e-03 | 17 | 136 | 2 | SM01332 | |
| Domain | TPR-like_helical_dom | 7.24e-03 | 233 | 136 | 6 | IPR011990 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 DOCK3 SLK ARHGEF28 ABR DOCK11 ARHGAP10 SRGAP2 MFN1 CCNE1 NDC80 WDR11 PIK3C3 SRGAP1 CENPI KIF5B VAV2 | 1.68e-05 | 720 | 103 | 17 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 SLK ARHGEF28 ABR DOCK11 ARHGAP10 SRGAP2 MFN1 CCNE1 NDC80 WDR11 PIK3C3 SRGAP1 CENPI KIF5B VAV2 | 1.81e-05 | 649 | 103 | 16 | MM15690 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 5.98e-05 | 184 | 103 | 8 | M41809 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 6.36e-05 | 94 | 103 | 6 | MM15598 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 ABR MAOA ARHGAP10 TTC21A ACP3 TMEM212 ATP9B SRGAP2 CPT1A ZNF462 EFNA1 POGLUT1 WDR11 GUCY1A1 PIK3C3 SUPT6H TTC12 PRKAG1 CCAR1 PBX1 PBX2 VAV2 FRMD3 RAVER1 | 2.41e-09 | 1489 | 144 | 25 | 28611215 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | UBR1 RARS1 VPS33A AIP CPT1A PIK3C3 SUPT6H CDC16 PRKAG1 CCAR1 | 2.16e-08 | 212 | 144 | 10 | 33853758 |
| Pubmed | 6.95e-08 | 3 | 144 | 3 | 22559944 | ||
| Pubmed | 1.36e-07 | 12 | 144 | 4 | 14602571 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 2.77e-07 | 4 | 144 | 3 | 22559943 | |
| Pubmed | UBR1 SLK ARHGEF28 PARG ANKRD27 WDR11 DROSHA SHCBP1 ASB3 CCAR1 CRYBG3 PPIP5K2 EDEM1 RAVER1 | 5.85e-07 | 650 | 144 | 14 | 38777146 | |
| Pubmed | 8.24e-07 | 18 | 144 | 4 | 18664271 | ||
| Pubmed | 1.95e-06 | 22 | 144 | 4 | 11994280 | ||
| Pubmed | DOCK1 VPS33A CPT1A WDR11 PIK3C3 RASSF1 PRKAG1 CCAR1 ATG4C MAP3K15 KIF5B | 2.28e-06 | 437 | 144 | 11 | 20562859 | |
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 18755982 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.74e-06 | 94 | 144 | 6 | 21542922 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNJL SLK ABR INTS1 AIP CBLB SPECC1 BLK CCNE1 EFNA1 CDC16 RASSF1 PRKAG1 DDX60L LAS1L | 6.11e-06 | 910 | 144 | 15 | 36736316 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DOCK11 ETF1 AK9 USP9Y NEB VPS13D TRANK1 PIK3C2B CCAR1 RP1 DDX24 | 7.71e-06 | 497 | 144 | 11 | 36774506 |
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 16515781 | ||
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 8798481 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 8.17e-06 | 10 | 144 | 3 | 9247029 | |
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 8.17e-06 | 10 | 144 | 3 | 8636073 | |
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 9.73e-06 | 117 | 144 | 6 | 18996102 | |
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 16081599 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 1.12e-05 | 11 | 144 | 3 | 12584329 | |
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 9808187 | ||
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 9708406 | ||
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 10985305 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGEF28 DOCK11 SPATA18 SRGAP2 SPECC1 ANKRD27 VPS13D PIK3C2B PIK3C3 SRGAP1 PRMT5 KIF5B CRYBG3 PPIP5K2 | 1.48e-05 | 861 | 144 | 14 | 36931259 |
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 16514418 | ||
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 10208934 | ||
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 12077252 | ||
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 9341793 | ||
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 12551992 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | ABR RARS1 PTPN23 SRGAP2 CCNE1 PRICKLE3 SUPT6H CDC16 KIF5B LAS1L DDX24 RAVER1 | 1.53e-05 | 639 | 144 | 12 | 23443559 |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 33984363 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 27373832 | ||
| Pubmed | Vps26A and Vps26B subunits define distinct retromer complexes. | 1.70e-05 | 2 | 144 | 2 | 21920005 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26482848 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 34168658 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 7910944 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31822692 | ||
| Pubmed | Pbx1 is required for adult subventricular zone neurogenesis. | 1.70e-05 | 2 | 144 | 2 | 27226325 | |
| Pubmed | 1.93e-05 | 13 | 144 | 3 | 9394803 | ||
| Pubmed | 1.93e-05 | 13 | 144 | 3 | 23215766 | ||
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 17157319 | ||
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 12432077 | ||
| Pubmed | 2.46e-05 | 282 | 144 | 8 | 23667531 | ||
| Pubmed | DOCK1 DOCK3 ARHGEF28 ABR DOCK11 ARHGAP10 SRGAP2 SSB SRGAP1 SHCBP1 CCAR1 PPIP5K2 VAV2 RAVER1 | 2.91e-05 | 916 | 144 | 14 | 32203420 | |
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 3.05e-05 | 15 | 144 | 3 | 18854243 | |
| Pubmed | 3.67e-05 | 218 | 144 | 7 | 19460752 | ||
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 20019835 | ||
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 21029719 | ||
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 20818790 | ||
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 3.74e-05 | 16 | 144 | 3 | 16524887 | |
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 11289809 | ||
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 4.53e-05 | 17 | 144 | 3 | 18453587 | |
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 4.53e-05 | 17 | 144 | 3 | 12960231 | |
| Pubmed | RARS1 ARHGAP10 CWC27 PHF12 INTS1 HIP1R SRGAP2 SPECC1 WDR11 SUPT6H DROSHA CDC16 PRMT5 CCAR1 TAF5 LAS1L PLS3 INO80E | 4.96e-05 | 1497 | 144 | 18 | 31527615 | |
| Pubmed | The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. | 5.09e-05 | 3 | 144 | 2 | 15169896 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 10679934 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29402992 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 16190980 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12609849 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11468159 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9482739 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 19137586 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 34965419 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 38517158 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17353115 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 37507586 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 5.29e-05 | 231 | 144 | 7 | 36597993 | |
| Pubmed | HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. | 5.42e-05 | 18 | 144 | 3 | 12526811 | |
| Pubmed | 6.42e-05 | 19 | 144 | 3 | 24073214 | ||
| Pubmed | 8.75e-05 | 21 | 144 | 3 | 9446795 | ||
| Pubmed | 8.90e-05 | 251 | 144 | 7 | 29778605 | ||
| Pubmed | 1.01e-04 | 22 | 144 | 3 | 11154208 | ||
| Pubmed | Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis. | 1.02e-04 | 4 | 144 | 2 | 24098492 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 16782872 | ||
| Pubmed | Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa. | 1.02e-04 | 4 | 144 | 2 | 26806561 | |
| Pubmed | PBX1 acts as terminal selector for olfactory bulb dopaminergic neurons. | 1.02e-04 | 4 | 144 | 2 | 32156753 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 33649309 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.02e-04 | 4 | 144 | 2 | 10469592 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 20810653 | ||
| Pubmed | Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. | 1.02e-04 | 4 | 144 | 2 | 18723445 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 23031429 | ||
| Pubmed | PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. | 1.02e-04 | 4 | 144 | 2 | 1682799 | |
| Pubmed | PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models. | 1.02e-04 | 4 | 144 | 2 | 27548528 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 8661110 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ABR PHF12 ETF1 SPATA18 SSB CNTLN SUPT6H CDC16 CCAR1 LAS1L DDX24 | 1.16e-04 | 670 | 144 | 11 | 22990118 |
| Pubmed | 1.16e-04 | 23 | 144 | 3 | 23301033 | ||
| Pubmed | 1.16e-04 | 23 | 144 | 3 | 19047410 | ||
| Pubmed | 1.16e-04 | 23 | 144 | 3 | 18691704 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RARS1 ETF1 INTS1 SSB VPS26A ANKRD27 LGALS9 VPS52 PRMT5 EIF2B3 PRKAG1 CCAR1 TAF5 PPIP5K2 LAS1L DDX24 | 1.20e-04 | 1318 | 144 | 16 | 30463901 |
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 1.30e-04 | 62 | 144 | 4 | 16641997 | |
| Pubmed | Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. | 1.50e-04 | 25 | 144 | 3 | 17632570 | |
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 1.50e-04 | 25 | 144 | 3 | 15689238 | |
| Pubmed | 1.55e-04 | 192 | 144 | 6 | 20602615 | ||
| Pubmed | 1.64e-04 | 277 | 144 | 7 | 30745168 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 KIFBP VPS33A INTS1 HIP1R NDC80 CDC16 PRKAG1 LAS1L RAVER1 | 1.65e-04 | 582 | 144 | 10 | 20467437 |
| Pubmed | Identification of novel retromer complexes in the mouse testis. | 1.69e-04 | 5 | 144 | 2 | 18656452 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.69e-04 | 5 | 144 | 2 | 12629516 | |
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 18973687 | ||
| Pubmed | Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking. | 1.69e-04 | 5 | 144 | 2 | 21040701 | |
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 1.69e-04 | 5 | 144 | 2 | 38230761 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q12 | 1.47e-04 | 84 | 144 | 4 | chr4q12 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 5.87e-06 | 23 | 95 | 4 | 1288 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 7.72e-06 | 8 | 95 | 3 | 831 | |
| GeneFamily | NLR family | 2.97e-04 | 25 | 95 | 3 | 666 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.50e-04 | 115 | 95 | 5 | 769 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.30e-03 | 50 | 95 | 3 | 721 | |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 3.14e-06 | 119 | 137 | 7 | M41139 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.77e-07 | 195 | 138 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.99e-07 | 198 | 138 | 8 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 138 | 8 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-07 | 155 | 138 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-07 | 155 | 138 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-07 | 169 | 138 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 171 | 138 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 171 | 138 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 188 | 138 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-06 | 189 | 138 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-06 | 189 | 138 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-06 | 191 | 138 | 7 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-06 | 191 | 138 | 7 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-06 | 191 | 138 | 7 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-06 | 192 | 138 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.34e-06 | 192 | 138 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 2.77e-06 | 197 | 138 | 7 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.23e-06 | 136 | 138 | 6 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.23e-06 | 136 | 138 | 6 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.23e-06 | 136 | 138 | 6 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.23e-06 | 136 | 138 | 6 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.23e-06 | 136 | 138 | 6 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Monocytes-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.80e-06 | 85 | 138 | 5 | e73603d6f22bb56159aa5d1a2695775f038e61d8 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.64e-06 | 154 | 138 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.64e-06 | 154 | 138 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.00e-05 | 158 | 138 | 6 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 1.04e-05 | 159 | 138 | 6 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 163 | 138 | 6 | 6c4d4c55fc8a731acca13c1ba7287f238a9d81e0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 165 | 138 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 165 | 138 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.73e-05 | 174 | 138 | 6 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.79e-05 | 175 | 138 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 177 | 138 | 6 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 179 | 138 | 6 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 181 | 138 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 181 | 138 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.23e-05 | 182 | 138 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.23e-05 | 182 | 138 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 183 | 138 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-05 | 184 | 138 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-05 | 184 | 138 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.44e-05 | 185 | 138 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 186 | 138 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 138 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.67e-05 | 188 | 138 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 188 | 138 | 6 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-05 | 189 | 138 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.75e-05 | 189 | 138 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.75e-05 | 189 | 138 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.84e-05 | 190 | 138 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.92e-05 | 191 | 138 | 6 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 191 | 138 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 191 | 138 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 191 | 138 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.01e-05 | 192 | 138 | 6 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 3.01e-05 | 192 | 138 | 6 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.19e-05 | 194 | 138 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 3.19e-05 | 194 | 138 | 6 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.19e-05 | 194 | 138 | 6 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-05 | 197 | 138 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.47e-05 | 197 | 138 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 3.78e-05 | 200 | 138 | 6 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-05 | 4 | 138 | 2 | 56c7f31259a515be31fc5b9fa42c327bbccab784 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-05 | 4 | 138 | 2 | cc578c54fb84d2827d656d483dc4b4bbeedad3e7 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 141 | 138 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 141 | 138 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 142 | 138 | 5 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.21e-05 | 146 | 138 | 5 | 8b2d104fdb0fdb09410450c6c651e1edb00cae44 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.82e-05 | 148 | 138 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.82e-05 | 148 | 138 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 150 | 138 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 154 | 138 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 154 | 138 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-04 | 156 | 138 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 1.50e-04 | 162 | 138 | 5 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 162 | 138 | 5 | 59c0dcb5b51c1803660aeec51b60deceeeaeea66 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 138 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 138 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 166 | 138 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 168 | 138 | 5 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 168 | 138 | 5 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 169 | 138 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 169 | 138 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-04 | 171 | 138 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| Disease | Drug habituation | 1.84e-04 | 115 | 134 | 5 | C0013170 | |
| Disease | Drug abuse | 1.84e-04 | 115 | 134 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.84e-04 | 115 | 134 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.84e-04 | 115 | 134 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.84e-04 | 115 | 134 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.84e-04 | 115 | 134 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.84e-04 | 115 | 134 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.84e-04 | 115 | 134 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.84e-04 | 115 | 134 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.92e-04 | 116 | 134 | 5 | C0740858 | |
| Disease | programmed cell death protein 5 measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0801927 | |
| Disease | tax1-binding protein 3 measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0802120 | |
| Disease | anorexia nervosa | 2.96e-04 | 70 | 134 | 4 | MONDO_0005351 | |
| Disease | Malignant neoplasm of breast | IL24 ABCA4 MAOA ZNF569 SPATA18 CPT1A ZDHHC4 CCNE1 NLRP14 EFNA1 PRICKLE3 ZNF432 KDR PLS3 | 3.90e-04 | 1074 | 134 | 14 | C0006142 |
| Disease | Cakut | 1.55e-03 | 13 | 134 | 2 | C1968949 | |
| Disease | interleukin 1 receptor antagonist measurement | 1.82e-03 | 53 | 134 | 3 | EFO_0004754 | |
| Disease | response to vaccine, cytokine measurement | 3.05e-03 | 131 | 134 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | carcinoma (implicated_via_orthology) | 3.12e-03 | 64 | 134 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | systemising measurement | 4.06e-03 | 21 | 134 | 2 | EFO_0010221 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.39e-03 | 145 | 134 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.42e-03 | 447 | 134 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Hepatitis | 4.46e-03 | 22 | 134 | 2 | HP_0012115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYEIHKEFYDNLCPK | 146 | Q12979 | |
| KSKEYLIACIEDHNY | 146 | Q96KX2 | |
| HYFEGVLKCYLHETL | 271 | P54619 | |
| LYSDANIYCQIDHKA | 226 | O75871 | |
| LVEHEKYCDQYRFAI | 301 | Q8NFR7 | |
| IQLCLEAYYDNTIFH | 41 | Q6UX04 | |
| ESISYQKLYNELHIC | 376 | Q9NXG0 | |
| DLHESTYKQEVYCNI | 2301 | Q68DQ2 | |
| YLECLVLDKFESYND | 516 | P78363 | |
| YFDQSHCGYLLEKDL | 931 | Q8IX12 | |
| KHCELNSYGFEELSY | 3971 | Q6V0I7 | |
| CEVYKLHRETFYLAQ | 156 | P24864 | |
| KECLKEYAHYFLEVT | 226 | Q8IV13 | |
| HLFCLYVVSKYLAVE | 656 | P50416 | |
| YSYLKEICDHQAEQL | 626 | Q5M775 | |
| VLLLGKCYHFKYEDE | 41 | Q96DT6 | |
| EYYEVLDHCSSILNK | 246 | O00170 | |
| HDLLSDYELKYCFVD | 76 | Q8IY67 | |
| HCIFIDDYLSYHELQ | 626 | Q9ULC6 | |
| EEEHLRQILQKYSYC | 316 | Q9NS23 | |
| LEIKYDFLYEKEHIC | 186 | Q96P65 | |
| DDYVLYLLESLHCQE | 461 | Q33E94 | |
| AHEDIKYEQACILYN | 106 | Q9H3S7 | |
| AYYDHVAVLLCLVVF | 181 | Q01726 | |
| LEFHIKVSYFEIYLD | 126 | P33176 | |
| NEFTCLDDVYHLYNL | 726 | Q6ZRR7 | |
| FDLSYNLNYHKLCSD | 501 | Q8IWA4 | |
| DQQICAYLEEKLHIY | 1226 | Q8N1W1 | |
| IETLNHEHYECKYVI | 256 | P21397 | |
| HEDCVKALVYYDVES | 541 | Q96NW4 | |
| DVHLVDHCKYKYLFN | 256 | Q8NBL1 | |
| RQHFYELSLEYVCKL | 171 | A1A4S6 | |
| YHTELEKYEQACNEF | 161 | P40424 | |
| IYHSELEKYEQACNE | 171 | P40425 | |
| AALEAKICHQIEYYF | 11 | P05455 | |
| CLHKVLFTEQPETYY | 611 | Q8N201 | |
| LDYVICHLDLYDSQS | 376 | Q8TC71 | |
| DSLEVCLKYYEHEFV | 821 | O43861 | |
| CLKVAVDGQHLFEYY | 316 | O00182 | |
| NLHFFYLVECYLVDL | 61 | Q5H9U9 | |
| LEAEHHQYIAKCLKY | 671 | Q5H9U9 | |
| DHIKVTQEQYELYCE | 351 | Q13191 | |
| FICDYELHELFKEAN | 31 | P13797 | |
| KLYPFIYHAVESCAE | 951 | Q86W56 | |
| KFSDCYIIHYIDDIL | 186 | P63132 | |
| DRLCLQDLLFKHYCY | 246 | Q9Y239 | |
| VADLHLNYEEAVLYC | 826 | O60449 | |
| VYLFCDDHKLQRYAL | 56 | Q9Y4W2 | |
| YDEFDLVLHKYLQAE | 261 | O75949 | |
| LVELEKEFHFNRYLC | 206 | P31249 | |
| FHDCKQKYDLYISIA | 126 | Q9BXC1 | |
| KFSDCYIIHYIDDIL | 186 | P63135 | |
| KLKFLIYEHECFQEE | 21 | Q8NBZ0 | |
| VDLLIYQTLCYTHDD | 401 | O00750 | |
| LGSHEYIQYCRKFDI | 441 | O00750 | |
| IHYFYCEILQLFKIS | 176 | Q9NZP5 | |
| VQTKEQYHFCYDIVL | 396 | Q4JDL3 | |
| QYHFCYDIVLEVLRK | 401 | Q4JDL3 | |
| ASCHLTELYFEKGEY | 311 | P15309 | |
| CQELLVDLIYFYHVG | 221 | O43900 | |
| KFSDCYIIHYFDDIL | 186 | Q9QC07 | |
| ETKGQFLIDHICNYY | 51 | A2A2Y4 | |
| FLIDHICNYYSLLEK | 56 | A2A2Y4 | |
| DAHLYCLKKYIVDFL | 201 | Q9NR50 | |
| RSLKNEELYHQSYDC | 871 | Q08462 | |
| ANELFYLSHKLVDLY | 281 | Q13042 | |
| ELHLAYCLKYEKFSI | 346 | Q9Y575 | |
| LCYIEKCHTYTLQEF | 331 | Q9C0G6 | |
| QDCSHLYHYTVKLLF | 221 | O75146 | |
| LEYSLSDEYCKHHFL | 1101 | Q5JSL3 | |
| LHKECDNYTEAAYTL | 1226 | Q14185 | |
| DIHELYVYKCDENST | 541 | Q8IZD9 | |
| QYILYLVEHEEYQLC | 66 | P20827 | |
| LDEDKHFVVALYDYT | 56 | P51451 | |
| CYLVHTLLEFYLKTV | 106 | Q13007 | |
| HHSEKEFCSYLQYLE | 271 | O14744 | |
| LSETCKYLYLLFDED | 551 | Q92611 | |
| EYYQSEAEGLLECHK | 176 | Q96A59 | |
| TKIHCETDEKDFYLY | 566 | Q9GZR7 | |
| FLLHFILDFYEKVCD | 556 | Q92674 | |
| YEDFIYHFTKLEICN | 401 | P20807 | |
| TSLEHYKFIVDYCEK | 571 | Q96EK5 | |
| YYVHKEELFDILHDT | 186 | Q6ZNG9 | |
| LDLCYNYLHDSLLKD | 191 | Q99983 | |
| EKTHNNDCYLDYSFV | 281 | P56715 | |
| HVTSCVYYKETLLND | 236 | Q6ZN16 | |
| NYNDVYSAFHVLCKE | 186 | Q9BPW5 | |
| QKILDDLFLHTLCDY | 586 | P54136 | |
| EYYSGLKHFIECSLD | 216 | Q15542 | |
| ALEYHNRIYICENKE | 1751 | Q5TCS8 | |
| AALYIDKDLEYVHTF | 1226 | Q9NRR4 | |
| YNLELTYEHFKSEEI | 171 | Q32P41 | |
| CDHPNIVKLLDAFYY | 86 | Q9H2G2 | |
| KYYIHDLSDLIDCCD | 256 | Q7Z6B7 | |
| FFEYVDILCNKHRLD | 26 | Q96LT4 | |
| YLQLFIYCAEDLHLK | 326 | A0AVI2 | |
| HCKYREDYFVTADQL | 276 | Q6ZMQ8 | |
| CIDQLLYSQDKHEYY | 161 | Q9Y2G5 | |
| NTYESHLLVCFLKRY | 476 | Q96NR3 | |
| KFHYIYSCDLDINVQ | 6 | Q8NEB9 | |
| ACIFYDENTKHYELL | 841 | Q96QT6 | |
| KYYIHDLSDLIDQCC | 266 | P0DJJ0 | |
| KYYIHDLSDLIDCCD | 266 | P0DMP2 | |
| DYHNLLSQCEESYRK | 246 | Q8NEM2 | |
| DYYHVDDLENLAKCH | 311 | O15516 | |
| KEKHYLTAFYIVECI | 316 | Q8TCW9 | |
| KFSDCYIIHYIDDIL | 186 | P63136 | |
| SFARDLLNHKYYQDC | 1421 | Q7KZ85 | |
| TLKHLDSYLADCYDA | 426 | Q8N1B4 | |
| CLHIEFEYNKSKYHL | 171 | Q4G0F5 | |
| VEYAHLYFFHCKLVL | 206 | Q9P2K2 | |
| YEEYHLTLQALDLCL | 141 | A6NML5 | |
| HCLQEVLKDYYTLVD | 331 | P10745 | |
| YNKDLEYLGKCHSDL | 691 | Q8NB66 | |
| YTTEDLIKHYNCGDL | 246 | A6NFA1 | |
| EVFGYCQELELSLHY | 86 | Q9NPG8 | |
| KYYIHDLSDLIDQCC | 266 | O75044 | |
| KFSDCYIIHYIDDIL | 186 | P10266 | |
| KFSDCYIIHYIDDIL | 186 | P63133 | |
| CIFYDTEHLKYHTQI | 716 | Q5JSH3 | |
| EKNERYYCVLFNDEH | 221 | Q8IWV7 | |
| YESYLDCELTKFLLD | 621 | O00329 | |
| KFSDCYIIHYIDDIL | 186 | Q9UQG0 | |
| TVIKEYINECDSDYH | 856 | O00507 | |
| ICIQFAEHYLAEKEY | 891 | Q8NDW8 | |
| CSYSEHQEKNDVFLY | 611 | Q6IQ21 | |
| DKHCFELYGYDILID | 316 | Q3SXZ7 | |
| LYEYDLFGKCLEHNF | 136 | Q5MCW4 | |
| EDCLHIEFEYNKSKY | 171 | O75436 | |
| CLFRENHDTFELYIK | 121 | O94892 | |
| YAIKILAICTNSYHE | 581 | Q9H892 | |
| QLCYYETKHTEELDS | 2331 | Q96JM2 | |
| YKDFLTLEHLICYSF | 996 | P35968 | |
| KECYLEGDQTSLYHA | 161 | Q96AX1 | |
| KFDSLLELVEYYQCH | 736 | P52735 | |
| LELVEYYQCHSLKES | 741 | P52735 | |
| IYDCIKYDVQHNGSL | 726 | O43314 | |
| HLSYLAKVLCGYENV | 2481 | O15050 | |
| LLLETSADNQHYYCD | 1016 | Q9BZH6 | |
| HTGEKLYEYKECHQI | 311 | Q8WXB4 | |
| YLICVAYSLQHSKED | 151 | Q96IK0 | |
| EAIFLEVKYDDLYHC | 4296 | Q5THJ4 | |
| FECYLYGVDFLTLHK | 106 | Q14584 | |
| YVLHCQGTEEEKILY | 331 | P62495 | |
| LCLDKEDDFLHVYYF | 191 | Q02108 | |
| QKDINCERYYSFIHL | 501 | P59046 | |
| IQKDAEYENCYVFTH | 466 | Q86W24 | |
| ELFHCLYETQDKAFI | 581 | Q86W24 | |
| EFESVLHKYLQSEEY | 281 | B1AL88 | |
| HNKLFLDYTIKCYES | 221 | O14777 | |
| CQTLVSDVDYKNYLH | 3101 | P20929 |